Work

Comparison of different treatment modalities for favorable risk acute myeloid leukemia: Standard-dose anthracycline versus high-dose anthracycline versus addition of gemtuzumab ozogamicin.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.e19016

Authors: Joseph Mort, Leah Wells, Samantha DiBenedetto, Emily Morse, Ben Mautner, Farid Ghamsari, Eric Pierce, Amy Morris, Michael Kenneth Keng, Firas El Chaer

Institutions: University of Virginia Health System, University of Virginia

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281664559

Cites:

Cited by:

Related to: 10